Voyager Therapeutics Stock Price on December 5, 2024
| VYGR Stock | USD 6.21 0.13 2.05% |
Below is the normalized historical share price chart for Voyager Therapeutics extending back to November 11, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Voyager Therapeutics stands at 6.21, as last reported on the 12th of December 2024, with the highest price reaching 6.21 and the lowest price hitting 6.21 during the day.
If you're considering investing in Voyager Stock, it is important to understand the factors that can impact its price. Currently, Voyager Therapeutics is moderately volatile. Voyager Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0311, which indicates the firm had a 0.0311% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Voyager Therapeutics, which you can use to evaluate the volatility of the company. Please validate Voyager Therapeutics' Coefficient Of Variation of 3195.47, risk adjusted performance of 0.0313, and Semi Deviation of 4.7 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.
At this time, Voyager Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 12/12/2024, Issuance Of Capital Stock is likely to grow to about 32.7 M, while Common Stock Shares Outstanding is likely to drop slightly above 29.7 M. . At this time, Voyager Therapeutics' Price Earnings Ratio is relatively stable compared to the past year. As of 12/12/2024, Price To Operating Cash Flows Ratio is likely to grow to 4.89, while Price Book Value Ratio is likely to drop 1.46. Voyager Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of November 2015 | 200 Day MA 7.6973 | 50 Day MA 6.5804 | Beta 0.889 |
Voyager |
Sharpe Ratio = 0.0311
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VYGR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.57 actual daily | 49 51% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Voyager Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Voyager Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.0237 | Enterprise Value Ebitda 2.6978 | Price Sales 2.1245 | Shares Float 36.3 M | Wall Street Target Price 17.1 |
Related Headline
Sarepta Therapeutics Headline on 5th of December 2024
Disposition of 1636 shares by Boor Kathryn Jean of Sarepta T... by MacroaxisInsider
Filed transaction by Sarepta Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Voyager Therapeutics Valuation on December 5, 2024
It is possible to determine the worth of Voyager Therapeutics on a given historical date. On December 5, 2024 Voyager was worth 6.26 at the beginning of the trading date compared to the closed value of 6.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Voyager Therapeutics stock. Still, in general, we apply an absolute valuation method to find Voyager Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Voyager Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Voyager Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 6.53 | 6.53 | 6.24 | 6.29 | 515,045 | |
12/05/2024 | 6.26 | 6.33 | 6.13 | 6.24 | 354,138 |
| 6.28 | 6.58 | 6.26 | 6.45 | 362,800 |
| Backtest Voyager Therapeutics | | | Voyager Therapeutics History | | | Voyager Therapeutics Valuation | Previous | Next |
Voyager Therapeutics Trading Date Momentum on December 5, 2024
| On December 06 2024 Voyager Therapeutics was traded for 6.45 at the closing time. The top price for the day was 6.58 and the lowest listed price was 6.26 . The trading volume for the day was 362.8 K. The trading history from December 6, 2024 was a factor to the next trading day price gain. The trading price change against the next closing price was 3.37% . The trading price change against the current closing price is 1.60% . |
Voyager Therapeutics Fundamentals Correlations and Trends
By evaluating Voyager Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Voyager Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Voyager financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Voyager Therapeutics Stock history
Voyager Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Voyager is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Voyager Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Voyager Therapeutics stock prices may prove useful in developing a viable investing in Voyager Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 44.6 M | 29.7 M | |
| Net Loss | -41.8 M | -43.9 M |
Voyager Therapeutics Quarterly Net Working Capital |
|
Voyager Therapeutics Stock Technical Analysis
Voyager Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Voyager Therapeutics Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Voyager Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Voyager Therapeutics December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Voyager Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Voyager Therapeutics shares will generate the highest return on investment. By undertsting and applying Voyager Therapeutics stock market strength indicators, traders can identify Voyager Therapeutics entry and exit signals to maximize returns
Voyager Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Voyager Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Voyager Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Voyager to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0313 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | 0.009 | |||
| Treynor Ratio | 0.0518 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Voyager Stock Analysis
When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.